hs-cTnI reagent (chemiluminescence assay)
Hs-cTnl
Gold standard of the AMI diagnosis
Ultra sensitivecTnltesting, earlier and more sensitive for AMI diagnosis
Recommended to purchase after comparing with Siemens ADVIA Centaur TnI-Ultra
Clinical significance
Diagnose AMI
Estimate infarct size and risk stratification, prognosis evaluation of AMI patients. Assist
to diagnose heart failure, evaluate heart functional status of patients
Advantage
High sensitivity:0.02ng/ml , real ultra sensitive cTnItest.
High accuracy:99% correlation with SiemensADVIA Centaur TnI-Ultra
Result correlation analysis between NormancTnI and ADVIA Centaur TnI-Ultra
Comparison between hs-cTnI and cTnl
Clinical significanceTest requirement
Content ,hs-ctnilctnl
earlist result time 1 to 3 hrsafter chest pain3 to 8 hrsafter chest pain
minimal myocardial injurysensitive insensitive
misdiagnosis rate low high
sensitivity requirement 0.02ng/ml 0.05ng/ml
methodology high sensitivity (chemiluminescence) common (colloidal gold,
fluorescence, turbidity
CV (99 percentile)<10%>10%
Relation between treatment time and death rate
Time death rate
after AMI, treated within 1 hr about 1%
after AMI, treated within 6 hrs about 10%-12%
every 30 mins delay increase 1%
Agent Wanted
If you are interested in working with us, please feel free to contact.
